 Immunologic responses ivermectin treatment patients onchocerciasis effect ivermectin treatment immunologic status individuals onchocerciasis patients Guatemala intervals years repeated semiannual treatment ivermectin cell proliferative responses onchocercal antigen months mean stimulation index SI preivermectin levels Changes SI antigen parasite antigen significant decreases levels blood eosinophils polyclonal IgG IgE parasite-specific IgG antibody IgG subclass antibodies end study study apparent long-term safety ivermectin absence immunopathogenic responses ivermectin treatments